Background: Stroke is a public health concern, and the emergence of the COVID-19 virus has made the continuation of social support/rehabilitation groups for stroke survivors difficult. Many stroke survivors have been required to self-isolate for 12 weeks or more, according to government rules and regulations. This has led to the use of innovative technological platforms (eg Zoom) for delivering rehabilitation activities through ‘life after stroke’ group sessions, such as choir practice for stroke survivors. Aims: The purpose of this study was to explore stroke survivors' experiences and perceptions of engaging, or choosing not to engage, in a virtual choir (VC) during the COVID-19 pandemic. Methods: Eight participants were recruited from the Stroke Association Strike a Chord VC. Semi-structured interviews were conducted, and the verbatim transcriptions were analysed using thematic analysis. Findings: Three main themes were identified: experience of singing in a choir; VCs and me; and yearning to sing face-to-face, with respective subthemes. The experience and perceptions presented here are intertwined. While most stroke survivors perceived the VC as a positive platform for providing a sense of belonging (community), there was a sense of yearning for face-to-face singing. Conclusions: This research may offer some support for those facilitating social and meaningful virtual group activities to groups in communities that may struggle with communication and digital literacy.
The aim of this prospective multicentre observational study was to assess the clinical performance and safety of Cutimed® Siltec® Sorbact® absorbent bacteria-binding foam dressing in wound healing and its impact on patients' quality of life (QoL). The study was conducted under routine clinical conditions in 5 study sites in Germany and Poland. Each patient with a venous leg ulcer (VLU) or a diabetic foot ulcer (DFU) was observed for 28 days (initial visit and close-out visit, as well as 3 control visits). An assessment of QoL of the patient was undertaken before and after the study. Sixty-two patients were included in the statistical analysis. Clinicians rated the following assessment parameters in relation to Cutimed Siltec Sorbact dressings as ‘very good’ to ‘good’: wearing comfort (rated by the patient), application and removal, exudate absorption with or without compression and fluid retention capacity with or without compression and infection management. The use of Cutimed Siltec Sorbact dressing was beneficial in absorbing wound exudate (chi-square=28.45, P value<0.001), reduction of the viscosity of wound exudate (chi-square=25.63, P value<0.001), and there were more intact, less macerated, red and oedematous wound surroundings. There was also a 9% decrease in the number of infected wounds at the close-out visit. Analysis of the Wound-QoL measures demonstrated a reduction in the perception of performance parameters associated with wound infection. It can therefore be deduced that the use of Cutimed Siltec Sorbact was effective in wound management and had positive implications for patients' QoL.
Design can improve the quality of life of people living with dementia but creating successful design solutions is not simple, due to the complexity of the medical condition, and the ethical considerations of including those affected in design research and evaluation. This article describes research involving an interactive product, ‘HUG’, developed from academic research, to support the wellbeing of people living with advanced dementia, which is now commercially available. People affected by dementia were included at every stage in the design research process. The evaluation of HUG took place in both hospital and care home contexts with 40 participants living with dementia. In this paper, a qualitative hospital study is described, in which patients received a HUG on prescription. Findings reveal that although HUG was rejected by some, those patients who did accept it benefitted significantly. Not only did the device reduce distress, anxiety and agitation but it also helped with patient compliance in medical procedures, aspects of daily care and enhanced communication and socialisation. The Alzheimer’s Society’s accelerator partnership funding has enabled this product to be manufactured and made commercially available so that the benefits of this academic design research can be made more widely available to people living with dementia.
Wound healing is an intrinsic and dynamic process. Wound exudate is a normal feature of wound healing; however, when there is insufficient or excessive production, or the composition of the exudate is harmful, wound healing may be compromised with resulting psychosocial and financial implications. Therefore, the management of exudate is essential for improved patient outcomes and in the prevention of future complications. The purpose of these studies, carried out in Germany and Poland, was to observe and to evaluate the clinical performance of Cutimed® Siltec® and Cutimed Siltec B on patients' wounds. Three visits (initial visit, dressing change visit and final visit) were scheduled and documented. In all, 129 patients took part in these studies and 150 wounds were treated. The results were pooled. Positive attributes of using these dressings included a decrease in exudate, intact wound margins and a decrease in pain during dressing changes. Clinicians and patients were satisfied with the product and rated the following parameters as ‘good’ to ‘very good’: wearing comfort, ease of application and removal, absorption and retention capacity, adaptability to the affected body part, absorption and retention capacity under compression. The results from this study suggest that Cutimed Siltec and Cutimed Siltec B absorbent dressings are beneficial in wound management due to the positive attributes, and clinicians and patients showed satisfaction with these dressings.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.